Delivery Order SPE2DB20D1004-SPE2DB24FG6C4

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,277.67 firm fixed-price delivery order contract has an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,021.64 and is a Firm Fixed Price Delivery Order, running through June 7, 2024. There was no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,323.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,563,681,036 units of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract has a ceiling value of $1,433.08 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through February 16, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $6,397.20. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,751.57 for the delivery of Telmisartan 40 mg tablets. The contract has a period of performance through November 28, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen has established Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.54 firm fixed-price delivery order is for the supply of 4,567,299,271 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
The federal contract award detailed is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,435.52 with a firm fixed price and a completion date of December 18, 2024. This award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,590.30, is for the delivery of 4563348505 - Telmisartan 40 mg Tablets in 30-count packages. The award has an ultimate completion date of January 18, 2024 and is a Firm Fixed Price Delivery Order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,336.61, is for the delivery of Telmisartan 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 8, 2024. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG6C4
    Delivery Order

This federal contract award is for the delivery of telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a ceiling value of $3,661.09 and a completion date of August 8, 2024. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award is part of AmerisourceBergen's broader portfolio of federal contract awards with agencies such as the Department of Justice Federal Bureau of Investigation, demonstrating the company's critical role in supplying essential medical commodities to various government healthcare programs.

Generated 2/27/25, 10:56 AM